España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
CARISMA Therapeutics
CARM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
CARISMA Therapeutics (CARM) Forecast
News
Earnings
CARISMA Therapeutics (CARM) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for CARISMA Therapeutics (NASDAQ:CARM) Stock
CARISMA Therapeutics Stock (NASDAQ: CARM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 16, 2024
HC Wainwright & Co. Downgrades CARISMA Therap...
Benzinga Newsdesk
Thursday, December 12, 2024
D. Boral Capital Maintains Buy on CARISMA The...
Benzinga Newsdesk
Carisma Therapeutics shares are trading lower...
Benzinga Newsdesk
Baird Downgrades CARISMA Therapeutics to Neut...
Benzinga Newsdesk
Wednesday, December 11, 2024
Evercore ISI Group Downgrades CARISMA Therape...
Benzinga Newsdesk
Tuesday, December 10, 2024
BTIG Downgrades CARISMA Therapeutics to Neutr...
Benzinga Newsdesk
Monday, December 09, 2024
D. Boral Capital Maintains Buy on CARISMA The...
Benzinga Newsdesk
Carisma Therapeutics Announces Strategic Rest...
Benzinga Newsdesk
Monday, November 25, 2024
HC Wainwright & Co. Maintains Buy on CARISMA ...
Benzinga Newsdesk
Monday, November 18, 2024
D. Boral Capital Maintains Buy on CARISMA The...
Benzinga Newsdesk
Reported Sunday, Carisma Therapeutics Unveils...
Benzinga Newsdesk
Monday, November 11, 2024
D. Boral Capital Maintains Buy on CARISMA The...
Benzinga Newsdesk
Friday, November 08, 2024
Carisma Unveils Pre-Clinical Data On Anti-GPC...
Benzinga Newsdesk
Thursday, November 07, 2024
EF Hutton Maintains Buy on CARISMA Therapeuti...
Benzinga Newsdesk
CARISMA Therapeutics' Q3 Cash And Cash Equiva...
Benzinga Newsdesk
CARISMA Therapeutics Q3 2024 GAAP EPS $(0.31)...
Benzinga Newsdesk
Tuesday, November 05, 2024
Carisma Therapeutics To Present New Data On A...
Benzinga Newsdesk
Wednesday, October 30, 2024
This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Wednesday
Avi Kapoor
EF Hutton Initiates Coverage On CARISMA Thera...
Benzinga Newsdesk
Tuesday, September 10, 2024
Carisma Therapeutics Has Expanded Its In Vivo...
Benzinga Newsdesk
Thursday, August 08, 2024
Carisma Therapeutics shares are trading highe...
Benzinga Newsdesk
Carisma Anticipates Its Cash And Equivalents ...
Benzinga Newsdesk
CARISMA Therapeutics Q2 2024 GAAP EPS $(0.27)...
Benzinga Newsdesk
Tuesday, July 02, 2024
Carisma Therapeutics, On June 26, 2024, In Fu...
Benzinga Newsdesk
Friday, June 28, 2024
Why Are Carisma Therapeutics Shares Surging Friday?
Vaishali Prayag
Market-Moving News for June 28th
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on CARISMA...
Benzinga Newsdesk
Carisma Therapeutics shares are trading highe...
Benzinga Newsdesk
Thursday, June 27, 2024
Carisma Therapeutics shares are trading highe...
Benzinga Newsdesk
Carisma Therapeutics Collaborates With Modern...
Benzinga Newsdesk
Wednesday, June 26, 2024
In-Depth Examination Of 5 Analyst Recommendations For CARISMA Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on CARISMA...
Benzinga Newsdesk
Tuesday, June 25, 2024
Carisma Therapeutics shares are trading highe...
Benzinga Newsdesk
Carisma Therapeutics Says FDA Granted Fast Tr...
Benzinga Newsdesk
Friday, May 17, 2024
The Analyst Verdict: CARISMA Therapeutics In The Eyes Of 4 Experts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on CARISMA...
Benzinga Newsdesk
Thursday, May 16, 2024
Carisma Therapeutics Doses First Patient In P...
Benzinga Newsdesk
Friday, May 10, 2024
HC Wainwright & Co. Maintains Buy on CARISMA ...
Benzinga Newsdesk
Thursday, May 09, 2024
Carisma Therapeutics Says Cash And Equivalent...
Benzinga Newsdesk
CARISMA Therapeutics Q1 2024 GAAP EPS $(0.46)...
Benzinga Newsdesk
Wednesday, May 08, 2024
Carisma Therapeutics Announced New Data Demon...
Benzinga Newsdesk
Monday, April 22, 2024
Carisma Therapeutics To Present New Data At A...
Benzinga Newsdesk
Thursday, April 11, 2024
BTIG Initiates Coverage On CARISMA Therapeuti...
Benzinga Newsdesk
Tuesday, April 02, 2024
HC Wainwright & Co. Maintains Buy on CARISMA ...
Benzinga Newsdesk
Monday, April 01, 2024
CARISMA Therapeutics Q4 EPS $(0.52) Beats $(0...
Benzinga Newsdesk
Wednesday, January 10, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Thursday, December 14, 2023
Carisma Therapeutics Has Nominated Its First ...
Benzinga Newsdesk
Wednesday, November 29, 2023
HC Wainwright & Co. Reiterates Buy on CARISMA...
Benzinga Newsdesk
Tuesday, November 28, 2023
Carisma Therapeutics Secures FDA Clearance Of...
Benzinga Newsdesk
Thursday, November 09, 2023
CARISMA Therapeutics' Q3 Cash, Cash Equivalen...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
